Skip to Main Content

Paper Details

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Cell Rep
210
2018
3q, 5p, CASP8, FANCF, HPV, MAPK, Np63 oncogene, RAS, SCC, SCCs, Squamous Carcinomas, T, T-regulatory, T-regulatory, and Myeloid suppressor cells, TET1 demethylase, alternative promoter, chromatin, chromosomal, death, gene programs, genes, human papillomavirus, inflammation, miR944, microRNAs, multi, oxidative damage, squamous cell carcinomas, squamous cell stemness
Author NameAffiliation
Joshua D CampbellDana-Farber Cancer Institute, USA The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, USA Boston University School of Medicine
Christina YauUniversity of California, USA Buck Institute for Research on Aging
Christina YauUniversity of California, USA Buck Institute for Research on Aging
Reanne Bowlby
Reanne Bowlby
Yuexin LiuThe University of Texas MD Anderson Cancer Center
Yuexin LiuThe University of Texas MD Anderson Cancer Center
Huihui FanCenter for Epigenetics, Van Andel Research Institute
Chen WangMayo Clinic
Rehan AkbaniThe University of Texas MD Anderson Cancer Center
Rehan AkbaniThe University of Texas MD Anderson Cancer Center
Chad J CreightonThe University of Texas MD Anderson Cancer Center, USA Department of Medicine and Dan L Duncan Comprehensive Cancer Center Division of Biostatistics, Baylor College of Medicine
Andrew D CherniackDana-Farber Cancer Institute, USA The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University
Andrew D CherniackDana-Farber Cancer Institute, USA The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University
Hui ShenCenter for Epigenetics, Van Andel Research Institute
Hui ShenCenter for Epigenetics, Van Andel Research Institute
Pavana AnurOregon Health & Science University
David Neil HayesLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
David Neil HayesLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Susan BullmanDana-Farber Cancer Institute, USA The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University
Chandra Sekhar PedamalluDana-Farber Cancer Institute, USA The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University
Chandra Sekhar PedamalluDana-Farber Cancer Institute, USA The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University
Akinyemi I OjesinaUniversity of Alabama at Birmingham, USA Hudson Alpha Institute for Biotechnology
Akinyemi I OjesinaUniversity of Alabama at Birmingham, USA Hudson Alpha Institute for Biotechnology
Sara Sadeghi
Amy G Robertson
Amy G Robertson
Christopher C BenzBuck Institute for Research on Aging
Christopher C BenzBuck Institute for Research on Aging
Andre SchultzThe University of Texas MD Anderson Cancer Center
Lixia DiaoThe University of Texas MD Anderson Cancer Center
Pavel SumazinTexas Children's Cancer Center, Baylor College of Medicine
Lawrence A DonehowerCenter for Comparative Medicine, Baylor College of Medicine
Alexander J LazarThe University of Texas MD Anderson Cancer Center
Elsa R FloresMoffitt Cancer Center
Ronglai ShenMemorial Sloan Kettering Cancer Center
Christopher K WongCenter for Biomolecular Sciences and Engineering University of California
Joshua M StuartCenter for Biomolecular Sciences and Engineering University of California
Joshua M StuartCenter for Biomolecular Sciences and Engineering University of California
Peter W LairdCenter for Epigenetics, Van Andel Research Institute
Peter W LairdCenter for Epigenetics, Van Andel Research Institute
Katherine A HoadleyUniversity of North Carolina at Chapel Hill
Katherine A HoadleyUniversity of North Carolina at Chapel Hill
John N WeinsteinThe University of Texas MD Anderson Cancer Center
John N WeinsteinThe University of Texas MD Anderson Cancer Center
Myron PetoOregon Health & Science University
Carter Van WaesNational Institute on Deafness and Other Communication Disorders
Carter Van WaesNational Institute on Deafness and Other Communication Disorders
  • 1 - 48

Datasets